Patient characteristics, treatment patterns, and survival across estrogen receptor expression subgroups in HER2-negative breast cancer: a population-based cohort study

This publication has 20 references indexed in Scilit:

• Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis
  Breast Cancer, 2025
• Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up
  ESMO Open, 2025
• Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment
  Clinical Breast Cancer, 2024
• The Conflicting Prognostic Role of the Stroma–Tumor Ratio in Breast Cancer Molecular Subtypes
  Laboratory Investigation, 2024
• Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer
  JNCI: Journal of the National Cancer Institute, 2024
• Immune landscape of breast tumors with low and intermediate estrogen receptor expression
  npj Breast Cancer, 2023
• RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
  npj Breast Cancer, 2022
• Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
  JNCI: Journal of the National Cancer Institute, 2018
• Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression
  Histopathology, 2014
• Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates
  Journal of Clinical Epidemiology, 1995